Aravind Immaneni
Insider
First SEC filing: Nov. 16, 2016 · Latest: March 20, 2018
Insider at
Insider transactions
0 buys (P)
0 sells (S)
Net: $0
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| March 19, 2018 | FITB | S | 2,000 | $33.65 | $67,300 | 21,071 Direct | -8.67% | Disposed | 51.6% (price as of 2026-10-06) |
| March 19, 2018 | FITB | S | 2,000 | $33.55 | $67,100 | 23,071 Direct | -7.98% | Disposed | 52.0% (price as of 2026-10-06) |
| Feb. 3, 2018 | FITB | F | 1,064 | $33.13 | $35,250 | 25,071 Direct | -4.07% | Disposed | 53.9% (price as of 2026-10-06) |
| Nov. 14, 2017 | FITB | F | 2,108 | $28.61 | $60,310 | 26,135 Direct | -7.46% | Disposed | 78.3% (price as of 2026-10-06) |
| Feb. 3, 2017 | FITB | A | 9,050 | · | · | 28,243 Direct | +47.15% | Acquired | (price as of 2026-10-06) |
| Feb. 3, 2017 | FITB | A | 10,526 | · | · | 10,526 Direct | · | Acquired | (price as of 2026-10-06) |
| Nov. 14, 2016 | FITB | A | 19,193 | · | · | 19,193 Direct | · | Acquired | (price as of 2026-10-06) |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II) Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| Feb. 3, 2017 | FITB | Stock Appreciation Rights | Common Stock | $26.52 | Feb. 3, 2027 | 10,526 | Acquired |
Exercise/conversion price is blank when not applicable (e.g. RSUs).
Initial ownership (Form 3) 1 holding
Securities held when first becoming an insider, per SEC Form 3.
| Date | Ticker | Security | Shares | Ownership |
|---|---|---|---|---|
| Nov. 16, 2016 | FITB | No securities beneficially owned | 0 | Direct |